Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. The company is headquartered in Smiths Falls, Canada.
| Revenue (TTM) | $284.60M |
| Gross Profit (TTM) | $79.55M |
| EBITDA | $-26.75M |
| Operating Margin | -24.70% |
| Return on Equity | -44.70% |
| Return on Assets | -3.88% |
| Revenue/Share (TTM) | $0.95 |
| Book Value | $1.16 |
| Price-to-Book | 0.87 |
| Price-to-Sales (TTM) | 1.50 |
| EV/Revenue | 1.819 |
| EV/EBITDA | 11014.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 9.60% |
| Shares Outstanding | $422.15M |
| Float | $421.75M |
| % Insiders | 0.25% |
| % Institutions | 7.88% |
Volatility is currently expanding
Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
The latest trading day saw Canopy Growth Corporation (CGC) settling at $0.95, representing a -1.04% change from its previous close.
As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.
Canopy Growth Corporation (CGC) closed at $0.95 in the latest trading session, marking a -4.45% move from the prior day.
While cannabis investors finally have an expedited DEA administrative hearing on the calendar and a fresh Schedule III pathway in motion, Wall Street has stood at this exact intersection before.
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Canadian cannabis sector continues to evolve in 2026. Several leading companies are improving profitability while expanding international operations. At the same time, investors remain focused on revenue growth, cash flow, and market share gains. As legalization efforts continue globally, Canadian operators remain positioned to benefit from new opportunities.
Canopy Growth Corporation (CGC) concluded the recent trading session at $0.96, signifying a -1.04% move from its prior day's close.
A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressure on legal operators to make the necessary adjustments to remain compliant. However, this also impacts marijuana stock investors both in the short and long term.
Canopy Growth Corporation operates across recreational, medical, and cannabinoid-based cannabis markets. I previously rated CGC a Hold, noting that potential cannabis rescheduling benefits seemed priced in. Despite optimism, CGC's subsequent performance validated a more cautious or even bearish stance.
